健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

赞助:
合作者:
信息的提供 (责任方):
October 1, 2018
October 3, 2018
October 3, 2018
November 2018
November 2020   (主要结果测量的最终数据收集日期)
amount (mg) of narcotics (oral morphine mg equivalents) used[ Time Frame: 6 Months ]
Number of mgs taken of oral morphine

duration of narcotic use[ Time Frame: 6 Months ]
Number of days on morphine post surgery

patient reported pain scores using VAS score[ Time Frame: 6 Months ]
Using a ruler, the score is determined by mea-suring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

与当前相同
  • [ Time Frame: ]
 
Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery
Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

This is a phase I, randomized, single-blind, placebo-controlled, single-center study of the effects of surgical site injection on pain and narcotic utilization in participants who undergo surgery for lower extremity fractures. 200 participants with lower extremity fractures who are admitted for operative fixation will be included in the study. Participants will be randomized to receive either a pain cocktail injection around the fracture site and surrounding tissues or control (no injection). An analysis of pain scores, rehabilitation progress, length of stay, narcotic utilization, and satisfaction scores will be performed.

Interventional
Phase 4
分配: Randomized
干预模型: Parallel Assignment
干预模型描述:
盲法: Interventional
盲法描述:
主要目的: Treatment
  • Drug: Marcaine, Duramorph , ketorolac
    Subjects in the SSI group will receive an injection of 40cc 0.25% Marcaine, 5 mg Duramorph (1 mg/cc, 5 cc total), and 30 mg of ketorolac (30 mg/cc, 1 cc total) into the periosteum, and musculature surrounding the fracture site and 0.25% Bupivacaine (Marcaine) 10 mL into the subcutaneous tissue surrounding the surgical incision.
  • Drug: Bupivacaine (Marcaine)
    0.25% Bupivacaine (Marcaine) 10 mL into the subcutaneous tissue surrounding the surgical incision.
  • Experimental: Spinal Anesthesia
    Injection of 40cc 0.25% Marcaine, 5 mg Duramorph (1 mg/cc, 5 cc total), and 30 mg of ketorolac (30 mg/cc, 1 cc total) into the periosteum, and musculature surrounding the fracture site and 0.25% Bupivacaine (Marcaine) 10 mL into the subcutaneous tissue surrounding the surgical incision.
  • No Intervention: General Anesthesia
    The control group will receive no injection into area surrounding the fracture site
 
Not yet recruiting
400
与当前相同
November 2020
November 2020   (主要结果测量的最终数据收集日期)
Inclusion Criteria: - Lower extremity fracture including femoral neck, intertrochanteric, sub-trochanteric, and femoral shaft fracture Exclusion Criteria: - Pregnant women - Treatment with Arthroplasty - Patients who receive a peripheral nerve block - Patients who receive intra-op or post-op ketamine - Patients with concomitant TBI or MR - Polytrauma patients - Pathologic Fractures - Patients who live greater than 10 miles from NYU or who will not be followed by an NYU provider - Patients with a contraindication to any of the medications on the study list due to other medical problems such as renal or liver disease or due to allergy/intolerance - Patients with prior extremity weakness resulting from stroke or other neurological condition - Prior or current history of narcotic use - Patients with advanced dementia - NYUMC Students, Residents, Faculty
参与研究的性别: All
最小年龄:18 Years ,最大年龄:N/A  
没有
United States
 
No
研究美国FDA监管的药品: Yes
研究涉及美国FDA监管的设备产品: No
计划分享 IPD: Yes
New York University School of Medicine
Principal Investigator: Philipp Leucht, MD New York University School of Medicine
October 2018

ICMJE     国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素
请使用微信扫码报名